Login / Signup

The antiviral state of the cell: lessons from SARS-CoV-2.

Jérémie Le PenCharles M Rice
Published in: Current opinion in immunology (2024)
In this review, we provide an overview of the intricate host-virus interactions that have emerged from the study of SARS-CoV-2 infection. We focus on the antiviral mechanisms of interferon-stimulated genes (ISGs) and their modulation of viral entry, replication, and release. We explore the role of a selection ISGs, including BST2, CD74, CH25H, DAXX, IFI6, IFITM1-3, LY6E, NCOA7, PLSCR1, OAS1, RTP4, and ZC3HAV1/ZAP, in restricting SARS-CoV-2 infection and discuss the virus's countermeasures. By synthesizing the latest research on SARS-CoV-2 and host antiviral responses, this review aims to provide a deeper understanding of the antiviral state of the cell under SARS-CoV-2 and other viral infections, offering insights for the development of novel antiviral strategies and therapeutics.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • single cell
  • cell therapy
  • stem cells
  • genome wide
  • coronavirus disease
  • mesenchymal stem cells